Scientists discover network of cells and genes involved in Crohn’s disease complication
On Jun. 30, 2025, the Broad Institute announced that spatial mapping reveals genes contributing to fibrosis, or scarring,…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO Scientific advisory group issues report on origins of COVID-19
On Jun. 27, 2025, the World Health Organization (WHO) Scientific Advisory Group for the Origins of Novel Pathogens…
Researchers take first steps to creating synthetic human genomes
On Jun. 26, 2025, a team of UK-based scientists announced they are developing technology to create the first…
TSU Breaks Ground on New $90 Million Agriculture Facilities
On Jun. 26, 2025, Tennessee State University leaders, dignitaries, and College of Agriculture faculty broke ground on the…
New Mexico announces measles outbreak in a county detention facility
On Jun. 26, 2025, the New Mexico Department of Health (NMDOH) announced that five people who are incarcerated…
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
On Jun. 25, 2025, Femasys announces Conformité Européene (CE) mark certification under European Union Medical Device Regulation of…
Penn engineers turn toxic fungus into anti-cancer drug
On Jun. 25, 2025, researchers at the University of Pennylvanis’s School of Engineering and Applied Science announced they…
Agriculture | Biotechnology | Cartoons - Original | Clinical Research | Cloning | COVID-19 | Diagnostics | FDA | Genomics | Infectious Disease | Marine Science | Medical Device | NIH | Non-Profit Research | Oncology | Stem Cell | Therapeutics | U.S. Congress | USDA | Vaccine | Veterinary | Women's Health
NIH will reinstate 900 grants in response to court order
On Jun. 25, 2025, the National Institutes of Health (NIH) moved to reinstate about 900 grants that a…
Biotechnology | COVID-19 | HIV | Infectious Disease | Influenza | Measles | Polio | Vaccine
Amid multi-state measles outbreak, Poll Shows 79% of Americans support routine childhood vaccine requirements
On Jun. 25, 2025, in the midst of a multi-state measles outbreak, a poll by Harvard T.H. Chan…
Biotechnology | COVID-19 | HIV | Infectious Disease | Influenza | Measles | NIH | Polio | U.S. Congress | Vaccine | Women's Health
U.S. to stop financial support of global vaccine alliance Gavi
On Jun. 25, 2025, the U.S. will announced it will no longer contribute funding to Gavi, a global…
Oregon’s first measles case of 2025 confirmed in Multnomah County
On Jun. 24, 2025, the Oregon Health Authority and county public health officials announced they are investigating a…
Texas Reports no New Measles cases in Ongoing outbreak
On Jun. 24, 2025, the Texas Department of State Health Services (DSHS) reported a total of 750 cases…
Biotechnology | COVID-19 | Infectious Disease | Measles | Polio | Vaccine | WHO
Millions of children at risk as childhood vaccination coverage stalls globally
On Jun. 24, 2025, the Institute for Health Metrics and Evaluation (IHME) announced results from the Global Burden…
First Case of Measles Identified in North Carolina
On Jun. 24, 2025, the North Carolina Department of Health and Human Services has confirmed a case of…
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults overweight or obesity in REDEFINE 1, published in NEJM
On Jun. 22, 2025, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Dupixent approved in the U.S. as the only targeted medicine to treat patients with bullous pemphigoid
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
Vertex Reports Positive Data for Zimislecel in Type 1 Diabetes
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA Announces Plan to Combat New World Screwworm’s Northward Spread
On Jun. 18, 2025, the U.S. Department of Agriculture announced it has launched an $8.5 million sterile New…
Molecular test confirms antimalarial antibody’s efficacy
On Jun. 18, 2025, researchers at the University of Washington (UW) School of Medicine announced that a highly…
Biotechnology | CDC | FDA | HIV | Infectious Disease | Medicine | Therapeutics
Yeztugo® (Lenacapavir) Is the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
Deadly listeria outbreak linked to chicken alfredo fettucine sold at Kroger and Walmart
On Jun. 18, 2025, federal health officials announced a listeria food poisoning outbreak that has killed three people…
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
Wastewater testing reveals measles virus in New Mexico sample
On Jun. 17, 2025, the New Mexico Department of Health (NMDOH) announced that wastewater in Deming has tested…
WHO Reports Higher Incidence of Cholera in Ongoing Outbreak
On Jun. 17, 2025, the World Health Organization (WHO) reported that from January 1, 2025 to May 25,…
Lilly to acquire Verve Therapeutics for $1 billion to advance one-time treatments for people with high cardiovascular risk
On Jun. 17, 2025, Eli Lilly and Verve Therapeutics, a Boston-based clinical-stage company developing genetic medicines for cardiovascular…
Texas Reports Six New Measles cases in West Texas
On Jun. 17, 2025, the Texas Department of State Health Services (DSHS) reported a total of 750 cases…
Supernus Pharmaceuticals to Acquire Sage Therapeutics
On Jun. 16, 2025, Supernus Pharmaceuticals and Sage Therapeutics announced a definitive agreement for Supernus to acquire Sage…
Scientists can now target the cells at the center of ALS
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
BrainStorm Announces New Survival Data from Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn
On Jun. 16, 2025, BrainStorm Cell Therapeutics announced new survival data from 10 participants in its Expanded Access…
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…